NRx Pharmaceuticals (NRXP) announced that it has entered into a binding agreement for a registered direct offering of its common stock with expected gross proceeds of $3.5M with certain ...

NRx Pharmaceuticals (NASDAQ:NRXP) stock rallied 35% Monday after its subsidiary HOPE Therapeutics announced the signing of a binding term sheet with Smith & Sauer for $25M in equity purchases to ...

Ascendiant Capital Markets increased their price target on shares of NRx Pharmaceuticals from $44.00 to $45.00 and gave the stock a “buy” rating in a research report on Monday, December 2nd.

NRx Pharmaceuticals (NRXP)’ wholly-owned subsidiary Hope Therapeutics signed a Stock Purchase Agreement with Smith & Sauer as the first step in a $27.0M financing to fund the planned acquisition ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a Delaware-based pharmaceutical company with a market capitalization of $61.63 million, announced the immediate resignation of Janet Rehnquist from its ...

Short interest in NRX Pharmaceuticals Inc (NASDAQ:NRXP) increased during the last reporting period, rising from 643.00K to 1.21M. This put 11.81% of the company's publicly available shares short.